BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Sun Q, Li X, Ma X, Li Y, Jiao Z, Yang X. Apigenin suppresses mouse peritoneal fibrosis by down-regulating miR34a expression. Biomedicine & Pharmacotherapy 2018;106:373-80. [DOI: 10.1016/j.biopha.2018.06.138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Fan K, Zhao Y, Xie ML. Apigenin attenuates TGF-β1-stimulated cardiac fibroblast differentiation and extracellular matrix production by targeting miR-155-5p/c-Ski/Smad pathway. J Ethnopharmacol 2021;265:113195. [PMID: 32800930 DOI: 10.1016/j.jep.2020.113195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 Wang Y, Shi Y, Tao M, Zhuang S, Liu N. Peritoneal fibrosis and epigenetic modulation. Perit Dial Int 2021;41:168-78. [PMID: 32662737 DOI: 10.1177/0896860820938239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Li N, Wang Z, Sun T, Lei Y, Liu X, Li Z. Apigenin Alleviates Renal Fibroblast Activation through AMPK and ERK Signaling Pathways In Vitro. Curr Pharm Biotechnol 2020;21:1107-18. [PMID: 32196447 DOI: 10.2174/1389201021666200320140908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ji J, Yu Q, Dai W, Wu L, Feng J, Zheng Y, Li Y, Guo C. Apigenin Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-β1/Smad3 and p38/PPARα Pathways. PPAR Res 2021;2021:6651839. [PMID: 33574836 DOI: 10.1155/2021/6651839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Guo Y, Wang L, Gou R, Tang L, Liu P. Noncoding RNAs in peritoneal fibrosis: Background, Mechanism, and Therapeutic Approach. Biomed Pharmacother 2020;129:110385. [PMID: 32768932 DOI: 10.1016/j.biopha.2020.110385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kashyap P, Shikha D, Thakur M, Aneja A. Functionality of apigenin as a potent antioxidant with emphasis on bioavailability, metabolism, action mechanism and in vitro and in vivo studies: A review. J Food Biochem 2021;:e13950. [PMID: 34569073 DOI: 10.1111/jfbc.13950] [Reference Citation Analysis]
7 Feng W, Ying Z, Ke F, Mei-Lin X. Apigenin suppresses TGF-β1-induced cardiac fibroblast differentiation and collagen synthesis through the downregulation of HIF-1α expression by miR-122-5p. Phytomedicine 2021;83:153481. [PMID: 33607460 DOI: 10.1016/j.phymed.2021.153481] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhou Y, Li X, Yuan X, Hao L. Role of allograft inflammatory factor-1 in the regulation of inflammation and oxidative stress in primary peritoneal mesothelial cells. Cell Biol Int 2019;43:495-505. [PMID: 30761680 DOI: 10.1002/cbin.11115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Li Z, Paulin D, Lacolley P, Coletti D, Agbulut O. Vimentin as a target for the treatment of COVID-19. BMJ Open Respir Res 2020;7:e000623. [PMID: 32913008 DOI: 10.1136/bmjresp-2020-000623] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Xu H, Wu T, Huang L. Therapeutic and delivery strategies of phytoconstituents for renal fibrosis. Adv Drug Deliv Rev 2021;177:113911. [PMID: 34358538 DOI: 10.1016/j.addr.2021.113911] [Reference Citation Analysis]